In an effort to reduce back pain through early intervention techniques, some investigators have focused upon nerves contained within the vertebral bodies.
For example, PCT Patent Publication No. WO 01/0157655 (“Heggeness”) discloses ablating nerves contained within the vertebral body by first boring into the vertebral body with a nerve ablation device, placing the tip of the device in close proximity to the nerve, and then ablating the nerves with the tip. Heggeness discloses numerous devices, such as electricity transmitting probes, as candidate nerve ablation devices. In describing how to use such a probe, Heggeness discloses “raising the temperature of tip 24 such that the intraosseous nerve is ablated by the heat generated by electrical current passing through tip.” See Heggeness at page 8, line 28. The probe disclosed by Heggeness appears to be a solid metal rod functioning as the active electrode of a monopolar RF device.
U.S. Pat. No. 6,478,793 (“Cosman”) discloses ablative treatment of metastatic bone tumors, including those within the spine. Pain relief is reportedly achieved by penetrating the bone wall with a suitable probe, and applying heat through the probe to ablate either the bone tumor or the tissue near the bone tumor. Cosman teaches the use of both monopolar and bipolar probes in this application. See Cosman at col. 5, line 44. Cosman also teaches that the treatment may also be used to ablate the nerves and nerve ramifications in and/or around the bone to desensitize them against further tumor encroachment. See Cosman at col. 8, lines 50-65, and col. 9, lines 9-17.
The only probes specifically disclosed by Cosman appear to be monopolar. However, monopolar approaches require the use of a grounding pad beneath the patient and allows energy to flow from the probe and to dissipate in the surrounding tissue. Because the path by which the energy flows from a monopolar probe to its corresponding pad is uncontrolled, the energy may undesirably flow through sensitive tissue, such as the spinal cord. Since this method may cause undesired local muscle or nerve stimulation, it may be difficult or dangerous to operate in sensitive areas of the human body.
Cosman teaches that the electrode may be rigid and robust and capable of piercing bone. Cosman teaches that the electrode may comprise a metal tubular shaft (with appropriate wall thickness to prevent buckling or bending during penetration of hard bone) with a rugged pointed tip. See Cosman at col. 6, lines 34-46. Beyond teaching the use of a generic bipolar probe, Cosman does not disclose any particular bipolar electrode configuration.
U.S. Pat. No. 6,168,593 (“Sharkey”) discloses thermal probes in which the electrodes are disposed at an angle to the longitudinal axis of the probe. In one embodiment, an electrode is located in a laterally-disposed window of a tubular, electrically insulating shaft. See
Although the probe disclosed in
Sharkey does not disclose a return and an active electrode located within the same window. Sharkey does not disclose a window in a conductive shaft. Sharkey does not disclose a probe having a tip adapted to penetrate bone.
U.S. Pat. No. 5,944,715 (“Goble”) discloses electrosurgical instruments wherein active electrodes 14 are housed within a window of an insulator. See
Like Sharkey, Goble does not disclose a return and an active electrode located within the same window, nor a window in a conductive shaft, nor a probe having a tip adapted to penetrate bone.
The present inventors have found that the shaft of a bipolar probe adapted to penetrate bone can be made by simply joining a solid, sharp tip onto a hollow tube. The resulting shaft is of sufficient strength to penetrate the cortical shell of a vertebral body. Furthermore, since the shaft comprises a hollow tube, wires for an electrode can be housed within the tube, thereby allowing a bipolar or sesquipolar configuration. The combination of the ability to penetrate a cortical shell and the ability to provide bipolar or sesquipolar function represents an advance over the conventional technology.
Therefore, in accordance with the present invention, there is provided an electrosurgical device, comprising:
In some embodiments, a space is provided between the tip and tube for ease of manufacturing.
Also in accordance with the present invention, there is provided an electrosurgical device, comprising:
In another aspect of the present invention, the present inventors have found that if the tubular portion of the shaft is made of an electrically conductive material and a window is formed in that tubular portion, then a simple and effective probe can be made by electrically insulating the rim of the window and then placing an electrode within the insulated window. This configuration allows the construction of a bipolar electrode having a simple and low cost design.
Therefore, in accordance with the present invention, there is provided an electrosurgical device, comprising:
Also in accordance with the present invention, there is provided an electrosurgical device, comprising:
In some embodiments, both the return and active electrodes are housed within the same window, thereby further reducing the complexity of the manufacturing process.
Therefore, in accordance with the present invention, there is provided an electrosurgical device, comprising:
a discloses a side view of a device of the present invention in which the device has been longitudinally cross-sectioned to reveal nesting features.
b discloses an exploded view of
a and 8b disclose distal tips of the present invention having chamfered features.
a-f disclose a circular transverse cross-sections of the sharp tip.
a discloses a device of the present invention having a means for delivering fluid that delivers fluid through a plurality of openings on the surface of the insulating spacer.
b discloses a transverse cross section of
a-b are cross-sections of devices of the present invention having slidable temperature probes.
c is a cross-section depicting various preferred locations for a temperature probe of a device of the present invention.
a-b are cross-sections of devices of the present invention having multi-sensor temperature probes.
a is a cross-section of a device of the present invention having radially segmented electrodes.
b is a side view of a device of the present invention having axially segmented electrodes.
a and 18b present axial and transverse cross-sectional views of an embodiment of the present invention in which the electrode surfaces are configured to allow current to flow out of only one side of the device.
a and 19b present axial cross-sectional views of a telescoping embodiment of the present invention in which the electrodes are in respective undeployed and deployed configurations.
For the purposes of the present invention, the “resistive heating zone” is the zone of bone tissue that is resistively heated due to an energy loss incurred by current traveling directly through the bone tissue. Resistive heating, “joule” heating and “near-field” heating may be used interchangeably herein. The “conductive heating zone” is the zone of bone tissue that is heated due to the conduction of heat from an adjacent resistive heating zone. The total heating zone (“THZ”) in a bone tissue includes both the resistive heating zone and the conductive heating zone. The border between the conductive and resistive heating zones is defined by the locations where the strength of the electric field is 10% of the maximum strength of the electric field between the electrodes. For the purposes of the present invention, the heating zones encompass the volume of bone tissue heated to at least 42° C. by the present invention. For the purposes of the present invention, the “first and second sides” of a vertebral body are the lateral-lateral sides intersected by the basivertebral nerve (“BVN”).
Preferably, the present invention comprises a novel probe adapted for piercing cortical bone and having a novel bipolar electrode configuration. More preferably, the present invention comprises a sharp stainless steel tip of sufficient sharpness to pierce cortical bone that is welded to one end of a hollow stainless steel shaft (or, “hypotube”). More preferably, a slot or window is cut into the distal portion of the shaft, thereby providing a window into which insulated electrodes can be placed. The insulation of the electrodes can be accomplished by providing an insulating material, such as a plastic insert or a potted encapsulant, between the inner rim of the window and the electrode.
This design is advantageous over conventional designs because it provides a relatively inexpensive device that is sufficiently rigid and strong to pierce cortical bone, thereby allowing its use for treating osseous nerves and bone tumors within the bone.
In some embodiments, the outer metal shaft of the inventive probe can be coated with an electrical insulator, such as PTFE to electrically insulate the shaft from the body tissue.
In another embodiment of the present invention, there is provided a radiofrequency (RF) applicator device (or “probe”) comprising a hollow rigid tube (such as stainless steel) fitted with a handle at its proximal end and an insulating spacer at its distal end, wherein a portion of the insulating spacer is nested within the distal end of the hollow tube. The proximal end of a distally disposed sharp tip is then nested through the spacer and into the distal end of the hollow tube, thereby imparting electrical isolation and greater strength to the assembled device. Preferably, the hollow tube is adapted to be a first electrode and the tip is adapted to be a second electrode, thereby forming a bipolar heating device adapted for treating hard tissue. Preferably, the device may optionally include channels or ports through which a conductive fluid, such as saline, can be delivered to the heating zone to improve the efficiency of the device.
Now referring to
The shaft of the present invention preferably comprises a hollow tube that allows at least one lead wire to be run therethrough. The material selection and dimensions of the shaft should be selected so as to allow the shaft to support the penetration of the cortical bone by the tip without yielding. Typically, the shaft is made of a metallic or ceramic material. Preferably, the shaft is made of a conductive material, such as a metal. Preferably, the metallic shaft material is selected from the group consisting of stainless steel, titanium, titanium-containing alloys, such as nitinol, copper, and copper plated with gold or platinum. More preferably, the metallic shaft material is stainless steel. In some embodiments, the shaft has a length of between 3 and 20 cm (preferably between 5 cm and 12 cm, an inner diameter of between 0.5 and 5 mm (preferably between 5 and 3 mm), and an outer diameter of between 1 and 6 mm (preferably between 2.0 and 4 mm). When the dimensions of the shaft are within these ranges, conventional biomaterials such as stainless steel can be suitably used.
In some embodiments, the proximal end of the spacer is received over the distal end of the shaft.
The function of the electrodes of the present invention is to be in direct contact with tissue and provide a pathway for RF current through a portion of the tissue surrounding the probe, thereby therapeutically heating the tissue. The electrodes are typically made of metals, such as stainless steel, platinum, gold, copper (nickel-plated or gold-plated), platinum, or a conductive polymer (such as a carbon- or silver-filled epoxy). Preferably, the electrode material of construction is such that its coefficient of thermal expansion is within 50% of the coefficient of thermal expansion of the material selected as the insulator 61.
The function of the insulating annulus of the present invention is to electrically insulate the electrodes located within the window from the electrically conductive shaft. The insulating annulus is typically made of PTFE, nylon, an epoxy, a polyurethane, a polyimide, or other suitable polymer, or a ceramic material.
Preferably, tip 51 provides two functions. First, its sharp tipped distal end 55 should be sufficiently pointed to penetrate cortical bone. Accordingly, although angle α may be any angle between about 0 degrees and about 90 degrees, angle α is preferably between 20 and 70 degrees. When the tip angle is below this range, the tip may be fragile and may be susceptible to breaking during cortical rim penetration. When the angle is above this range, the tip is too blunt and may require excessive force to achieve cortical rim penetration. In some embodiments, the proximal portion of the tip is solid, thereby providing additional strength to the tip. In some embodiments, the proximal portion of the tip has a diameter that substantially the same as the outer diameter of the shaft. In this condition, the proximal portion of the tip may be mechanically joined to the distal end of the shaft (for example, by welding) to produce a strong, streamlined probe.
In other embodiments, the sharp tipped distal end is formed near the axial center of the tip to produce a conical shape.
In some embodiments, the device further comprises an outer insulating sleeve (such as sleeve 71) surrounding at least the proximal portion of the hollow shaft. The function of the sleeve is to electrically isolate the device from the tissue that is adjacent the target tissue, thereby increasing the safety and effectiveness of the device. In some embodiments, the material of construction for the sleeve is selected from the group consisting of polymeric materials such as PTFE and ceramic materials such as alumina. In some embodiments, the sleeve is provided in the form of a coating upon the shaft. In other embodiments, the sleeve is manufactured separately and slid over the shaft. Typically, the sleeve has a length that is between 50% and 95% of the length of the shaft length. In some embodiments, the sleeve extends distally towards the window and terminates within one length of the window.
In some embodiments, the thermocouple is coupled to the power supply in a feedback loop to modulate the power output and thereby control the temperature at the tip.
Now referring to
In this configuration, the placement of an insulating sleeve preferably provides a distal uninsulated portion of the shaft having a length of between 3 mm and 20 mm, and is more preferably about 5 mm. In preferred embodiments thereof, the insulation is selected from the group consisting of polyimide tape, PTFE tape, and heat shrink tubing. One preferred thickness of the insulation ranges from about 0.006 mm to about 0.012 mm) (i.e., about 0.00025 to 0.0005 inches), and is provided by a dielectric coating, such as a polyimide coating.
Now referring to
Alternatively, in some embodiments, neither electrode completely traverses the transverse width of the tube. In some embodiments thereof, each electrode opens through a window on the same side of the tube. In other embodiments thereof, a first electrode opens through a first window on a first side of the tube, and a second electrode opens through a second window on a second side of the tube, preferably on a diametrically opposed side of the tube.
Now referring to
In some embodiments, and now referring to
In some embodiments, as in
The robust nature of the embodiment shown in
Similarly, the proximal end portion 523 of the sharp tip (the distal half 525 of which is preferably solid) can be made to extend so far proximally as to nest in the conductive shaft. Because the intervening spacer is made of an electrically insulating material, the conductive tip is electrically isolated from the conductive shaft. The proximal extension of the tip into the shaft likewise increases the robust nature of the probe.
Now referring to
Now referring to
Now referring to
Now referring to
If the active electrode has no active cooling means, it may become be subject to conductive heating induced by the heated tissue, and the resultant increased temperature at the electrode-tissue interface in the electrode may adversely affect performance by charring the adjacent bone tissue. Accordingly, in some embodiments, a cool tip active electrode may be employed. The cooled electrode helps maintain the temperature of the electrode at a desired temperature. Cooled tip active electrodes are known in the art. Alternatively, the power supply may be designed to provided a pulsed energy input. It has been found that pulsing the current favorably allows heat to dissipate from the electrode tip, and so the active electrode stays relatively cooler.
In some embodiments, and now referring to
In some embodiments, as in
Now referring to
Now referring to
In some embodiments, thermocouples are placed in radially extending hole portions of the fluid delivery tubes in order to monitor the surface temperature of the device at various radial locations. In these embodiments, the fluid delivery tube having a thermocouple therein is effectively blocked so that each tube has either a thermocouple or fluid delivery function, but not both.
Also as shown in this embodiment, the proximal portion 1211 of each fluid delivery tube can comprise a single inner wall 1213 and a single outer wall 1215 defining a single large diameter annulus 1217 therebetween. Fluid is delivered through this annulus to the proximal portion 1219 of the plurality of holes 1221 provided in the insulating spacer.
The annular nature of the proximal portion of the fluid delivery tube is also advantageous because it also provides a convenient inner tube 1223 through which a lead 1225 can be run to electrically connect the sharp tip 1227 to the power supply.
In general, it is desirable to operate the present invention in a manner that produces a peak temperature in the target tissue of between about 80° C. and 100° C. When the peak temperature is below 80° C., the off-peak temperatures may quickly fall below about 45° C. When the peak temperature is above about 100° C., the bone tissue exposed to that peak temperature may experience necrosis and charring. This charring reduces the electrical conductivity of the charred tissue, thereby making it more difficult to pass RF current through the target tissue beyond the char and to resistively heat the target tissue beyond the char. In some embodiments, the peak temperature is preferably between 90° C. and 98° C.
It is desirable to heat the volume of target tissue to a minimum temperature of at least 42° C. When the tissue experiences a temperature above 42° C., nerves within the target tissue may be desirably, damaged. However, it is believed that denervation is a function of the total quantum of energy delivered to the target tissue, i.e., both exposure temperature and exposure time determine the total dose of energy delivered. Accordingly, if the temperature of the target tissue reaches only about 42° C., then it is believed that the exposure time of the volume of target tissue to that temperature should be at least about 30 minutes and preferably at least 60 minutes in order to deliver the dose of energy believed necessary to denervate the nerves within the target tissue.
Preferably, it is desirable to heat the volume of target tissue to a minimum temperature of at least 50° C. If the temperature of the target tissue reaches about 50° C., then it is believed that the exposure time of the volume of target tissue to that temperature need only be in the range of about 2 minutes to 10 minutes to achieve denervation.
More preferably, it is desirable to heat the volume of target tissue to a minimum temperature of at least 60° C. If the temperature of the target tissue reaches about 60° C., then it is believed that the exposure time of the volume of target tissue to that temperature need only be in the range of about 0.5 minutes to 3 minutes to achieve denervation, preferably 1 minute to 2 minutes.
Typically, the period of time that an intraosseous nerve (“ION”) is exposed to therapeutic temperatures is in general related to the length of time in which the electrodes are at the target temperature following heat up. However, since it has been observed that the total heating zone remains relatively hot even after power has been turned off (and the electric field eliminated), the exposure time can include a period of time in which current is not running through the electrodes.
In some embodiments, it is desirable to heat the target tissue so that at least about 1 cm3 of bone tissue experiences the minimum temperature. This volume corresponds to a sphere having a radius of about 0.6 cm. Alternatively stated, it is desirable to heat the target tissue so the minimum temperature is achieved by every portion of the bone within 0.6 cm of the point experiencing the peak temperature.
More preferably, it is desirable to heat the target tissue so that at least about 3 cm3 of bone experiences the minimum temperature. This volume corresponds to a sphere having a radius of about 1 cm.
In one preferred embodiment, the present invention provides a steady-state heated zone having a peak temperature of between 80° C. and 100° C. (and preferably between 90° C. and 98° C.), and heats at least 1 cm3 of bone (and preferably at least 3 cm3 of bone) to a temperature of at least 50° C. (and preferably at least 60° C.).
As noted above, a peak temperature below about 100° C. is desirable in order to prevent charring of the adjacent tissue, steam formation and tissue popping. In some embodiments, this is accomplished by providing the power supply with a feedback means that allows the peak temperature within the heating zone to be maintained at a desired target temperature, such as 90-98° C. In some embodiments, between about 10 watts and 30 watts of power is first supplied to the device in order to rapidly heat the relatively cool bone, with maximum amperage being obtained within about 10 15 seconds. As the bone is further heated to the target temperature, the feedback means gradually reduces the power input to the device to between about 6 10 watts.
Although preferred embodiments of the present invention typically comprises bipolar electrodes, the probes of the present invention can be easily adapted to provide monopolar use. For example, the device of
The following section relates to the general structure of preferred energy devices in accordance with the present invention:
The apparatus according to the present invention comprises an electrosurgical probe having a shaft with a proximal end, a distal end, and at least one active electrode at or near the distal end. A connector is provided at or near the proximal end of the shaft for electrically coupling the active electrode to a high frequency voltage source. In some embodiments, a return electrode coupled to the voltage source is spaced a sufficient distance from the active electrode to substantially avoid or minimize current shorting therebetween. The return electrode may be provided integral with the shaft of the probe or it may be separate from the shaft.
In preferred embodiments, the electrosurgical device will comprise a shaft or a handpiece having a proximal end and a distal end which supports one or more electrodes. The shaft may assume a wide variety of configurations, with the primary purpose being to mechanically support the active electrode and permit the treating physician to manipulate the electrode from a proximal end of the shaft. The shaft may be rigid or flexible, with flexible shafts optionally being combined with a generally rigid external tube for mechanical support. Flexible shafts may be combined with pull wires, shape memory actuators, and other known mechanisms for effecting selective deflection of the distal end of the shaft to facilitate positioning of the electrode array. The shaft may include a plurality of wires or other conductive elements running axially therethrough to permit connection of the electrode array to a connector at the proximal end of the shaft.
In some embodiments, the shaft comprises a hollow annulus adapted to be introduced through a posterior percutaneous penetration in the patient. Thus, the shaft adapted for posterior percutaneous use may have a length in the range of about 3 to 25 cm (preferably, 12-15 cm), and a diameter in the range of about 1 mm to about 6 mm (preferably, 2-5 mm). However, for endoscopic procedures within the spine, the shaft will have a suitable diameter and length to allow the surgeon to reach the target site (e.g., a disc) by delivering the shaft through the thoracic cavity, the abdomen or the like. Thus, the shaft may have a length in the range of about 5.0 to 30.0 cm, and a diameter in the range of about 1 mm to about 6 mm (preferably, about 2 mm to about 4 mm). In any of these embodiments, the shaft may also be introduced through rigid or flexible endoscopes.
The probe further comprises one or more active electrode(s) for applying electrical energy to the cancellous region of the vertebral body. The probe may be bipolar and include one or more return electrode(s). In some embodiments thereof, the bipolar probe has an active electrode array disposed at its distal end. In other embodiments, the probe may be monopolar, whereby the return electrode may be positioned on the patient's back, as a dispersive pad. In either embodiment, sufficient electrical energy is applied through the probe to the active electrode(s) to heat the tissue in the target area and thereby denervate at least a portion of the basivertebral nerve within the vertebral body.
In some embodiments, the probe that is delivered percutaneously and/or endoluminally into the patient by insertion through a conventional or specialized guide catheter. The catheter shaft may include a guide wire for guiding the catheter to the target site, or the catheter may comprise a steerable guide catheter. The catheter may also include a substantially rigid distal end portion to increase the torque control of the distal end portion as the catheter is advanced further into the patient's body.
In some embodiments, the electrically conductive wires may run freely inside the catheter bore in an unconstrained made, or within multiple lumens within the catheter bore.
In some embodiments, the tip region of the device may comprise many independent electrode terminals designed to deliver electrical energy in the vicinity of the tip. The selective application of electrical energy is achieved by connecting each individual electrode terminal and the return electrode to a power source having independently controlled or current limited channels. The return electrode(s) may comprise a single tubular member of conductive material proximal to the electrode array. Alternatively, the instrument may comprise an array of return electrodes at the distal tip of the instrument (together with the active electrodes) to maintain the electric current at the tip. The application of high frequency voltage between the return electrode(s) and the electrode array results in the generation of high electric field intensities at the distal tips of the electrode terminals with conduction of high frequency current from each individual electrode terminal to the return electrode. The current flow from each individual electrode terminal to the return electrode(s) is controlled by either active or passive means, or a combination thereof, to deliver electrical energy to the surrounding conductive fluid while minimizing energy delivery to surrounding (non-target) tissue.
In some embodiments, the device further comprises at least one temperature probe. The temperature is preferably selected from the group consisting of a thermocouple, a thermistor, and a fiber-optic probe (and is preferably a thermocouple). Thermocouples associated with the device may preferably be disposed on or within the electrode carrier; between the electrodes (preferred in bipolar embodiments); or within the electrodes (preferred for monopolar embodiments). In some embodiments wherein the electrodes are placed on either side of the basivertebral nerve, a thermocouple is disposed between the electrodes or in the electrodes. In alternate embodiments, the deployable portion of the thermocouple comprises a memory metal.
One common characteristic of conventional thermal therapy devices is the dimensionally fixed nature of the temperature probe. Because of this fixed nature, the temperature probe can not be moved relative to the shaft, and so can not provide spatially-changing analysis unless the shaft is moved as well. Because it is often problematic to move the shaft, the fixed nature of the probe limits the extent of temperature analysis.
Now referring to
Therefore, in accordance with the present invention, there is provided a thermal therapy device comprising:
Although the device of
The temperature probe shown in
Therefore, is some embodiments of the present invention, there is provided a thermal therapy device 1331 having an axially-offset temperature probe. Now referring to
Locating the probe a position A allows the device to be easily manufactured. Locating temperature probe B located within the outer wall of the shaft allows the device to be easily manufactured and durable, and avoids biocompatibility issues. Locating third temperature probe C at the wall/tissue interface provides the most realistic estimate of the tissue temperature. Locating fourth temperature probe D at the electrode/insulator interface allows the device to be easily manufactured a provides measurement of a relatively hot region.
In general, bipolar and monopolar electrodes are used to apply a thermal therapy to tissue for a therapeutic effect. Many probes are actively temperature controlled to monitor and apply a certain thermal dose. Also, electrodes are often cooled (internally) to prevent charring near or on the probe tip and thus allow more power to hear tissue further away from the tip and to create a larger treatment zone. One major drawback to this type of device is that the system is not able monitor the temperature of the lesion. It only monitors the tip temperature, which is being cooled to 0° C., to allow more power to be put into the tissue and create a larger lesion.
In one embodiment of the present invention, and now referring to
Now referring to
The electrode terminal(s) are preferably supported within or by an insulating support positioned near the distal end of the device. The return electrode(s) may be located on the instrument shaft, on another instrument, or on the external surface of the patient (i.e., a dispersive pad). The return electrode is preferably integrated with the shaft. The proximal end of the shaft preferably includes the appropriate electrical connections for coupling the return electrode(s) and the electrode terminal(s) to a high frequency power supply, such as an electrosurgical generator.
In some embodiments, the distal end of the device has surface geometries shaped to promote the electric field intensity and associated current density along the leading edges of the electrodes. Suitable surface geometries may be obtained by creating electrode shapes that include preferential sharp edges, indented grooves, or by creating asperities or other surface roughness on the active surface(s) of the electrodes. Surface shapes according to the present invention can include the use of formed wire (e.g., by drawing round wire through a shaping die) to form electrodes with a variety of cross-sectional shapes, such as square, rectangular, L or V shaped, or the like. Edges may also be created by removing a portion of the elongate metal shaft to reshape the cross-section. For example, material can be ground along the length of a round or hollow shaft electrode to form D or C shaped electrodes, respectively, with edges facing in the cutting direction. Alternatively, material can be removed at closely spaced intervals along the shaft length to form transverse grooves, slots, threads or the like along the electrodes. In other embodiments, the shaft can be sectored so that a given circumference comprises an electrode region and an inactive region. In some embodiments, the inactive region is masked.
The return electrode is preferably spaced proximally from the active electrode(s) a suitable distance. In most of the embodiments described herein, the distal edge of the exposed surface of the return electrode is spaced about 2 to 25 mm from the proximal edge of the exposed surface of the active electrode(s). This distance may vary with different voltage ranges, the electrode geometry and depend on the proximity of tissue structures to active and return electrodes. The return electrode will typically have an exposed length in the range of about 1 to 20 mm. Preferably, the ratio of the exposed length of the return electrode to the active length of the active electrode is at least 2:1.
The present invention may use a single active electrode terminal or an array of electrode terminals spaced around the distal surface of the shaft. In the latter embodiment, the electrode array usually includes a plurality of independently current-limited and/or power-controlled electrode terminals to apply electrical energy selectively to the target tissue while limiting the unwanted application of electrical energy to the surrounding tissue and environment resulting from power dissipation into surrounding electrically conductive fluids, such as blood, normal saline, and the like. The electrode terminals may be independently current-limited by isolating the terminals from each other and connecting each terminal to a separate power source that is isolated from the other electrode terminals. Alternatively, the electrode terminals may be connected to each other at either the proximal or distal ends of the shaft to form a single wire that couples to a power source. Alternatively, different electrode terminals can be selected to be active, thereby modifying the path of current and subsequent lesion size and location.
In some embodiments, the plurality of active electrodes are radially staggered about the cross-section of the shaft. In some embodiments, the radially staggered electrodes are individually controllable.
Now referring to
In some embodiments, the plurality of active electrodes are axially segmented along the axis of the shaft. Now referring to
In one configuration, each individual electrode terminal in the electrode array is electrically insulated from all other electrode terminals in the array within the shaft, and is connected to a power source that is isolated from each of the other electrode terminals in the array or to circuitry that limits or interrupts current flow to the electrode terminal when a low resistivity material (e.g., blood) causes a lower impedance path between the return electrode and the individual electrode terminal. The isolated power sources for each individual electrode terminal may constitute separate power supply circuits having internal impedance characteristics that act to limit the supply of power to the associated electrode terminal when a low impedance return path is encountered. By way of example, the isolated power source may be a user-selectable constant current source. In this embodiment, lower impedance paths will automatically result in lower resistive heating levels since the heating is proportional to the square of the operating current times the impedance. Alternatively, a single power source may be connected to each of the electrode terminals through independently actuatable switches, or by independent current limiting elements, such as inductors, capacitors, resistors and/or combinations thereof. The current limiting elements may be provided in the shaft, connectors, cable, controller or along the conductive path from the controller to the distal tip of the device. Alternatively, resistance and/or capacitance may be provided on the surface of the active electrode terminal(s) by providing an oxide layer that forms selected electrode terminals (e.g., titanium or a resistive coating on the surface of metal, such as platinum).
In a preferred aspect of the invention, the active electrode comprises an electrode array having a plurality of electrically isolated electrode terminals disposed over a contact surface (which may be a planar or non-planar surface, and which may be located at the distal tip of the device or over a lateral surface of the shaft, or over both the tip and lateral surface(s)). The electrode array will include at least two and preferably more electrode terminals, and may further comprise a temperature sensor. In a preferred aspect, each electrode terminal will be connected to the proximal connector by an electrically isolated conductor disposed within the shaft. The conductors permit independent electrical coupling of the electrode terminals to a high frequency power supply and control system with optional temperature monitoring of the operation of the probe. The control system preferably incorporates active and/or passive current limiting structures, which are designed to limit current flow when the associated electrode terminal is in contact with a low resistance return path back to the return electrode.
The use of such electrode arrays in electrosurgical procedures is particularly advantageous as it has been found to limit the depth of tissue necrosis without substantially reducing power delivery. Since the shaft is hollow, a conductive fluid could be added through the annulus of the shaft and flow into the bone structure for the purposes of lowering the electrical impedance and filling the spaces in the cancellous bone to make the target tissue a better conductor.
Another characteristic of conventional thermal-therapy electrode devices is the dimensionally-fixed nature of the electrode. Because of this fixed nature, the electrode can not be moved relative to the shaft, and so can not provide spatially-changing therapy unless the shaft is moved as well. Because it is often problematic to move the shaft, the fixed nature of the electrode limits the extent of thermal therapy.
Now referring to
In some embodiments, each of the sliding electrodes is moved towards intermediate portion 1607. This results in a smaller gap between the electrodes and consequently a more compact heating pattern.
In some embodiments, each of the sliding electrodes is moved away from intermediate portion 1607. This results in a larger gap between the electrodes and consequently a more elongated heating pattern. If the gap is sufficiently large, then the heating pattern may form two essentially separate zones adjacent to the electrodes.
In some embodiments, each of the sliding electrodes is moved in the same direction (i.e., distally). This results in a more distal heating pattern.
Therefore, in accordance with the present invention, there is provided a thermal therapy device comprising:
Also in accordance with the present invention, there is provided a thermal therapy device comprising:
It should be clearly understood that the invention is not limited to electrically isolated electrode terminals, or even to a plurality of electrode terminals. For example, an array of active electrode terminals may be connected to a single lead that extends through the shaft to a power source of high frequency current. Alternatively, the device may incorporate a single electrode extending directly through the shaft or connected to a single lead that extends to the power source. The active electrode(s) may have a shape selected from the group consisting of a ball shape, a twizzle shapes, a spring shape, a twisted metal shape, a cone shape, an annular shape and a solid tube shape. Alternatively, the electrode(s) may comprise a plurality of filaments, rigid or flexible brush electrode(s), side-effect brush electrode(s) on a lateral surface of the shaft, coiled electrode(s) or the like.
The current applied between the return electrode(s) and the electrode terminal(s) is preferably a high or radio frequency current, typically between about 50 kHz and 20 MHz, usually being between about 100 kHz and 2.5 MHz, preferably being between about 400 kHz and 1000 kHz, often less than 600 kHz, and often between about 500 kHz and 600 kHz. The RMS (root mean square) voltage applied will usually be in the range from about 5 volts to 1000 volts, preferably being in the range from about 10 volts to 200 volts, often between about 20 to 100 volts depending on the electrode terminal size, the operating frequency and the operation mode of the particular procedure. Lower peak-to-peak voltages are preferred for thermal heating of tissue, and will typically be in the range from 100 to 1500, preferably 45 to 1000 and more preferably 45 to 80 volts rms. As discussed above, the voltage is usually delivered continuously with a sufficiently high frequency RF current (e.g., on the order of 50 kHz to 20 MHz) as compared with e.g., lasers that produce small depths of necrosis and are generally pulsed about 10 to 20 Hz. In addition, the sine wave duty cycle (i.e., cumulative time in any one-second interval that energy is applied) is preferably on the order of about 100% for the present invention, as compared with pulsed lasers which typically have a duty cycle of about 0.0001%.
The power source allows the user to select the power level according to the specific requirements of a particular procedure. The preferred power source of the present invention delivers a high frequency current selectable to generate average power levels ranging from several milliwatts to tens of watts per electrode, depending on the volume of target tissue being heated, and/or the maximum allowed temperature selected for the device tip.
The power source may be current limited or otherwise controlled so that undesired heating of the target tissue or surrounding (non-target) tissue does not occur. In one embodiment of the present invention, current limiting inductors are placed in series with each independent electrode terminal, where the inductance of the inductor is in the range of 10 uH to 50,000 uH, depending on the electrical properties of the target tissue, the desired tissue heating rate and the operating frequency. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described previously in U.S. Pat. No. 5,697,909. Additionally, current limiting resistors may be selected. Preferably, microprocessors are employed to monitor the measured current and control the output to limit the current.
The area of the tissue treatment surface can vary widely, and the tissue treatment surface can assume a variety of geometries, with particular areas and geometries being selected for specific applications. The geometries can be planar, concave, convex, hemispherical, conical, linear “in-line” array or virtually any other regular or irregular shape. Most commonly, at least one of the active electrode(s) or electrode terminal(s) will be formed at the distal tip of the device, and is frequently planar, disk-shaped, or hemispherical. Alternatively or additionally, the active electrode(s) may be formed on lateral surfaces of the electrosurgical instrument shaft (e.g., in the manner of a spatula), facilitating access to certain body structures in endoscopic procedures.
The devices of the present invention may be suitably used for insertion into any hard or soft tissue in the human body, but are most advantageously used in hard tissue. In some embodiments, the hard tissue is bone. In other embodiments, the hard tissue is cartilage. In preferred embodiments when bone is selected as the tissue of choice, the bone is a vertebral body. Preferably, the present invention is adapted to puncture the hard cortical shell of the bone and penetrate at least a portion of the underlying cancellous bone. In some embodiments, the probe advances into the bone to a distance of at least ⅓ of the cross-section of the bone defined by the advance of the probe.
In some embodiments, there is provided a preferred procedure comprising a first step of penetrating the hard cortical bone with a sharp tipped biopsy needle housed in a cannula, and a second step of delivering a device of the present invention having a radiused or bullet nose through the cannula through the location of pierced bone.
In some embodiments, the present invention is practiced in vertebral bodies substantially free of tumors. In others, the present invention is practiced in vertebral bodies having tumors.
In some embodiments, the target region of the basivertebal nerve (BVN) is located within the cancellous portion of the bone (i.e., to the interior of the outer cortical bone region), and proximal to the junction of the BVN having a plurality of branches. Treatment in this region is advantageous because only a single portion of the BVN need be effectively treated to denervate the entire system. In contrast, treatment of the BVN in locations more downstream than the junction require the denervation of each branch.
In another embodiment, as in
In some embodiments of the present invention, the insulation and/or electrode geometries are selected to provide a more directional flow of current out of the device. In some embodiments, the electrode portions and insulating portions of the device are configured so that current flows through a hemi-cylindrical portion of a transverse cross-section of the device. For example, in some embodiments, as shown in
Although the embodiment shown in
In other embodiments, the active electrode surface area may change along the longitudinal axis, thereby varying the heating profile. For example, the active electrode surface may taper from a proximal 180° arc to a distal 90° arc.
In some embodiments, there is provided a device having a telescoping deployment of the electrodes. Now referring to
In some embodiments, the hollow outer shaft contains one or more electrodes 1904 located on or near the distal end 1911 of the hollow outer shaft.
In some embodiments, deployment of the electrodes is carried out by a simple sliding motion.
In others, the inner portion of the outer shaft and the outer portion of the inner shaft comprise complementary threadforms, so that the relative rotation of one of the shafts causes linear distal displacement of the inner shaft. The mechanical advantage provided by this embodiment provides the clinician with an increased force and increased precision.
In another embodiment, the inner portion of the outer shaft and the outer portion of the inner shaft form a complementary pin-and-helical groove structure. This embodiment allows for a more rapid deployment of the electrodes to a fixed distal position.
Deployment mechanisms for these embodiments are well known in the art and are preferably located in part upon the proximal portion of a handle of the device.
This telescoping embodiment advantageously provides the surgeon with an ability to adjust the location of an electrodes without moving the entire probe. That is, the surgeon may treat a first location, adjust the location of the electrode by telescoping, and then treat a second location.
Therefore, in accordance with the present invention, there is provided a thermal therapy device comprising:
This prophetic example describes a preferred dual probe embodiment of the present invention.
First, after induction of an appropriate amount of a local anesthesia, the human patient is placed in a prone position on the table. The C-arm of an X-ray apparatus is positioned so that the X-rays are perpendicular to the axis of the spine. This positioning provides a lateral view of the vertebral body, thereby allowing the surgeon to view the access of the apparatus into the vertebral body.
Next, the device of the present invention is inserted into the skin at a lateral location so that its distal tip passes posterior to the dorsal nerves located outside the vertebral body.
Next, the device is advanced interiorly into the vertebral body so that the distal tip bores through the skin, into and through the cortical shell of the vertebral body. The device is advanced until the tip reaches the anterior-posterior midline of the vertebral body.
Next, the power supply is activated to provide a voltage between the active and return electrodes. The amount of voltage across the electrodes is sufficient to produce an electric current between the active and return electrodes. This current provides resistive heating of the tissue disposed between the electrodes in an amount sufficient to raise the temperature of the local portion of the basivertebral nerve (BVN) to at least 45° C., thereby denervating the BVN.
This application is a continuation of U.S. patent application Ser. No. 12/643,997, now abandoned, filed Dec. 21, 2009, which is a continuation of U.S. patent application Ser. No. 11/745,446, now abandoned, filed on May 7, 2007, which is a continuation of U.S. patent application Ser. No. 10/401,854 filed on Mar. 28, 2003, now U.S. Pat. No. 7,258,690, each of which is incorporated herein by reference in its entirety. This application is also related to U.S. patent application Ser. No. 10/259,689 filed on Sep. 30, 2002, now U.S. Pat. No. 7,326,203, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3845771 | Vise | Nov 1974 | A |
3920021 | Hiltebrandt | Nov 1975 | A |
4044774 | Corbin et al. | Aug 1977 | A |
4116198 | Roos | Sep 1978 | A |
4312364 | Convert et al. | Jan 1982 | A |
4448198 | Turner | May 1984 | A |
4573448 | Kambin | Mar 1986 | A |
4657017 | Sorochenko | Apr 1987 | A |
4679561 | Doss | Jul 1987 | A |
4754757 | Feucht | Jul 1988 | A |
4907589 | Cosman | Mar 1990 | A |
4950267 | Ishihara et al. | Aug 1990 | A |
4959063 | Kojima | Sep 1990 | A |
4963142 | Loertscher | Oct 1990 | A |
4966144 | Rochkind et al. | Oct 1990 | A |
5061266 | Hakky | Oct 1991 | A |
5080660 | Buelna | Jan 1992 | A |
5084043 | Hertzmann et al. | Jan 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5106376 | Mononen et al. | Apr 1992 | A |
5108404 | Scholten et al. | Apr 1992 | A |
5161533 | Prass et al. | Nov 1992 | A |
5190546 | Jervis | Mar 1993 | A |
5201729 | Hertzmann et al. | Apr 1993 | A |
5209748 | Daikuzono | May 1993 | A |
5222953 | Dowlatshahi | Jun 1993 | A |
5242439 | Larsen et al. | Sep 1993 | A |
5273026 | Wilk | Dec 1993 | A |
5281213 | Milder et al. | Jan 1994 | A |
5295484 | Marcus et al. | Mar 1994 | A |
5320617 | Leach | Jun 1994 | A |
5350377 | Winston et al. | Sep 1994 | A |
5366443 | Eggers et al. | Nov 1994 | A |
5368031 | Cline et al. | Nov 1994 | A |
5374265 | Sand | Dec 1994 | A |
5391197 | Burdette et al. | Feb 1995 | A |
5419767 | Eggers et al. | May 1995 | A |
5433739 | Sluijter et al. | Jul 1995 | A |
5437661 | Rieser | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5443463 | Stern et al. | Aug 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5458597 | Edwards et al. | Oct 1995 | A |
5472441 | Edwards et al. | Dec 1995 | A |
5484432 | Sand | Jan 1996 | A |
5486170 | Winston et al. | Jan 1996 | A |
5514130 | Baker | May 1996 | A |
5540684 | Hassler, Jr. | Jul 1996 | A |
5569242 | Lax et al. | Oct 1996 | A |
5571147 | Sluijter et al. | Nov 1996 | A |
5620479 | Diederich | Apr 1997 | A |
5630426 | Shmulewitz et al. | May 1997 | A |
5630837 | Crowley | May 1997 | A |
5643319 | Green et al. | Jul 1997 | A |
5647871 | Levine et al. | Jul 1997 | A |
5672173 | Gough et al. | Sep 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5693052 | Weaver | Dec 1997 | A |
5697281 | Eggers et al. | Dec 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5697927 | Imran et al. | Dec 1997 | A |
5700262 | Acosta et al. | Dec 1997 | A |
5720287 | Chapelon et al. | Feb 1998 | A |
5725494 | Brisken | Mar 1998 | A |
5728062 | Brisken | Mar 1998 | A |
5733280 | Avitall | Mar 1998 | A |
5733315 | Burdette et al. | Mar 1998 | A |
5735811 | Brisken | Apr 1998 | A |
5735847 | Gough et al. | Apr 1998 | A |
5738680 | Mueller et al. | Apr 1998 | A |
5743904 | Edwards | Apr 1998 | A |
5746737 | Saadat | May 1998 | A |
5752969 | Cunci et al. | May 1998 | A |
5762066 | Law et al. | Jun 1998 | A |
5762616 | Talish | Jun 1998 | A |
5766153 | Eggers et al. | Jun 1998 | A |
5776092 | Farin et al. | Jul 1998 | A |
5785705 | Baker | Jul 1998 | A |
5800378 | Edwards et al. | Sep 1998 | A |
5807392 | Eggers | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5817021 | Reichenberger | Oct 1998 | A |
5843019 | Eggers et al. | Dec 1998 | A |
5843021 | Edwards et al. | Dec 1998 | A |
5846218 | Brisken et al. | Dec 1998 | A |
5849011 | Jones et al. | Dec 1998 | A |
5855576 | LeVeen et al. | Jan 1999 | A |
5860951 | Eggers et al. | Jan 1999 | A |
5865788 | Edwards et al. | Feb 1999 | A |
5868740 | LeVeen et al. | Feb 1999 | A |
5871469 | Eggers et al. | Feb 1999 | A |
5871470 | McWha | Feb 1999 | A |
5871481 | Kannenberg et al. | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5873877 | McGaffigan et al. | Feb 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5895370 | Edwards et al. | Apr 1999 | A |
5902272 | Eggers et al. | May 1999 | A |
5904681 | West, Jr. | May 1999 | A |
5931805 | Brisken | Aug 1999 | A |
5935123 | Edwards et al. | Aug 1999 | A |
5941722 | Chen | Aug 1999 | A |
5941876 | Nardella et al. | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5948007 | Starkebaum et al. | Sep 1999 | A |
5948008 | Daikuzono | Sep 1999 | A |
5954716 | Sharkey et al. | Sep 1999 | A |
5964727 | Edwards et al. | Oct 1999 | A |
5983141 | Sluijter et al. | Nov 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
6001095 | de la Rama et al. | Dec 1999 | A |
6007533 | Casscells et al. | Dec 1999 | A |
6007570 | Sharkey et al. | Dec 1999 | A |
6012457 | Lesh | Jan 2000 | A |
6016452 | Kasevich | Jan 2000 | A |
6017356 | Frederick et al. | Jan 2000 | A |
6022334 | Edwards et al. | Feb 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6024740 | Lesh et al. | Feb 2000 | A |
6030402 | Thompson et al. | Feb 2000 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6035238 | Ingle et al. | Mar 2000 | A |
6045532 | Eggers et al. | Apr 2000 | A |
6050995 | Durgin | Apr 2000 | A |
6053172 | Hovda et al. | Apr 2000 | A |
6053909 | Shadduck | Apr 2000 | A |
6063079 | Hovda et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6073051 | Sharkey et al. | Jun 2000 | A |
6086585 | Hovda et al. | Jul 2000 | A |
6090105 | Zepeda et al. | Jul 2000 | A |
6095149 | Sharkey et al. | Aug 2000 | A |
6099514 | Sharkey et al. | Aug 2000 | A |
6102046 | Weinstein et al. | Aug 2000 | A |
6104957 | Alo et al. | Aug 2000 | A |
6105581 | Eggers et al. | Aug 2000 | A |
6109268 | Thaliyal et al. | Aug 2000 | A |
6113597 | Eggers et al. | Sep 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6117109 | Eggers et al. | Sep 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6120467 | Schallhorn | Sep 2000 | A |
6122549 | Sharkey et al. | Sep 2000 | A |
6139545 | Utley et al. | Oct 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6143019 | Motamedi et al. | Nov 2000 | A |
6146380 | Racz et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6159194 | Eggers et al. | Dec 2000 | A |
6159208 | Hovda et al. | Dec 2000 | A |
6161048 | Sluijter et al. | Dec 2000 | A |
6164283 | Lesh | Dec 2000 | A |
6165172 | Farley et al. | Dec 2000 | A |
6168593 | Sharkey et al. | Jan 2001 | B1 |
6176857 | Ashley | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6179836 | Eggers et al. | Jan 2001 | B1 |
6183469 | Thaliyal et al. | Feb 2001 | B1 |
6190381 | Olsen et al. | Feb 2001 | B1 |
6190383 | Schmaltz et al. | Feb 2001 | B1 |
6193715 | Wrublewski et al. | Feb 2001 | B1 |
6203542 | Ellsberry et al. | Mar 2001 | B1 |
6210393 | Brisken | Apr 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6210415 | Bester | Apr 2001 | B1 |
6221038 | Brisken | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6228046 | Brisken | May 2001 | B1 |
6228078 | Eggers et al. | May 2001 | B1 |
6228082 | Baker et al. | May 2001 | B1 |
6231571 | Ellman et al. | May 2001 | B1 |
6231615 | Preissman | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6235024 | Tu | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6241665 | Negus et al. | Jun 2001 | B1 |
6241725 | Cosman | Jun 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6246912 | Sluijter et al. | Jun 2001 | B1 |
6254553 | Lidgren et al. | Jul 2001 | B1 |
6254599 | Lesh et al. | Jul 2001 | B1 |
6254600 | Willink et al. | Jul 2001 | B1 |
6258086 | Ashley et al. | Jul 2001 | B1 |
6259952 | Sluijter | Jul 2001 | B1 |
6261311 | Sharkey et al. | Jul 2001 | B1 |
6264650 | Hovda et al. | Jul 2001 | B1 |
6264651 | Underwood et al. | Jul 2001 | B1 |
6264652 | Eggers et al. | Jul 2001 | B1 |
6264659 | Ross et al. | Jul 2001 | B1 |
6267770 | Truwit | Jul 2001 | B1 |
6277112 | Underwood et al. | Aug 2001 | B1 |
6277122 | McGahan et al. | Aug 2001 | B1 |
6280441 | Ryan | Aug 2001 | B1 |
6283961 | Underwood et al. | Sep 2001 | B1 |
6287114 | Meller et al. | Sep 2001 | B1 |
6287272 | Brisken et al. | Sep 2001 | B1 |
6287304 | Eggers et al. | Sep 2001 | B1 |
6290715 | Sharkey et al. | Sep 2001 | B1 |
6296619 | Brisken et al. | Oct 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6305378 | Lesh et al. | Oct 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6309420 | Preissman | Oct 2001 | B1 |
6312408 | Eggers et al. | Nov 2001 | B1 |
6312426 | Goldberg et al. | Nov 2001 | B1 |
6322549 | Eggers et al. | Nov 2001 | B1 |
6348055 | Preissman | Feb 2002 | B1 |
6355032 | Hovda et al. | Mar 2002 | B1 |
6363937 | Hovda et al. | Apr 2002 | B1 |
6379351 | Thaliyal et al. | Apr 2002 | B1 |
6383190 | Preissman | May 2002 | B1 |
6391025 | Weinstein et al. | May 2002 | B1 |
6416507 | Eggers et al. | Jul 2002 | B1 |
6416508 | Eggers et al. | Jul 2002 | B1 |
6423059 | Hanson et al. | Jul 2002 | B1 |
6432103 | Ellsberry et al. | Aug 2002 | B1 |
6436060 | Talish | Aug 2002 | B1 |
6451013 | Bays et al. | Sep 2002 | B1 |
6454727 | Burbank et al. | Sep 2002 | B1 |
6461350 | Underwood et al. | Oct 2002 | B1 |
6461354 | Olsen et al. | Oct 2002 | B1 |
6464695 | Hovda et al. | Oct 2002 | B2 |
6468270 | Hovda et al. | Oct 2002 | B1 |
6468274 | Alleyne et al. | Oct 2002 | B1 |
6478793 | Cosman et al. | Nov 2002 | B1 |
6482201 | Olsen et al. | Nov 2002 | B1 |
6500173 | Underwood et al. | Dec 2002 | B2 |
6527759 | Tachibana et al. | Mar 2003 | B1 |
6540741 | Underwood et al. | Apr 2003 | B1 |
6544261 | Ellsberry et al. | Apr 2003 | B2 |
6557559 | Eggers et al. | May 2003 | B1 |
6558385 | McClurken et al. | May 2003 | B1 |
6560486 | Osorio et al. | May 2003 | B1 |
6575968 | Eggers et al. | Jun 2003 | B1 |
6582423 | Thaliyal et al. | Jun 2003 | B1 |
6585656 | Masters | Jul 2003 | B2 |
6589237 | Woloszko et al. | Jul 2003 | B2 |
6595990 | Weinstein et al. | Jul 2003 | B1 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6622731 | Daniel et al. | Sep 2003 | B2 |
6632193 | Davison et al. | Oct 2003 | B1 |
6632220 | Eggers et al. | Oct 2003 | B1 |
6659106 | Hovda et al. | Dec 2003 | B1 |
6699242 | Heggeness | Mar 2004 | B2 |
6726684 | Woloszko et al. | Apr 2004 | B1 |
6736835 | Pellegrino et al. | May 2004 | B2 |
6746447 | Davison et al. | Jun 2004 | B2 |
6749604 | Eggers et al. | Jun 2004 | B1 |
6758846 | Goble et al. | Jul 2004 | B2 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6772012 | Ricart et al. | Aug 2004 | B2 |
6773431 | Eggers et al. | Aug 2004 | B2 |
6827716 | Ryan et al. | Dec 2004 | B2 |
6832996 | Woloszko et al. | Dec 2004 | B2 |
6837887 | Woloszko et al. | Jan 2005 | B2 |
6837888 | Ciarrocca et al. | Jan 2005 | B2 |
6863672 | Reiley et al. | Mar 2005 | B2 |
6875219 | Arramon et al. | Apr 2005 | B2 |
6881214 | Cosman et al. | Apr 2005 | B2 |
6896674 | Woloszko et al. | May 2005 | B1 |
6907884 | Pellegrino et al. | Jun 2005 | B2 |
6915806 | Pacek et al. | Jul 2005 | B2 |
6922579 | Taimisto et al. | Jul 2005 | B2 |
6923813 | Phillips et al. | Aug 2005 | B2 |
6960204 | Eggers et al. | Nov 2005 | B2 |
6974453 | Woloszko et al. | Dec 2005 | B2 |
7048743 | Miller et al. | May 2006 | B2 |
7090672 | Underwood et al. | Aug 2006 | B2 |
7131969 | Hovda et al. | Nov 2006 | B1 |
7177678 | Osorio et al. | Feb 2007 | B1 |
7179255 | Lettice et al. | Feb 2007 | B2 |
7186234 | Dahla et al. | Mar 2007 | B2 |
7192428 | Eggers et al. | Mar 2007 | B2 |
7201731 | Lundquist et al. | Apr 2007 | B1 |
7201750 | Eggers et al. | Apr 2007 | B1 |
7211055 | Diederich et al. | May 2007 | B2 |
7217268 | Eggers et al. | May 2007 | B2 |
7258690 | Sutton et al. | Aug 2007 | B2 |
7270659 | Ricart et al. | Sep 2007 | B2 |
7270661 | Dahla et al. | Sep 2007 | B2 |
7276063 | Davison et al. | Oct 2007 | B2 |
7318823 | Sharps et al. | Jan 2008 | B2 |
7326203 | Papineau et al. | Feb 2008 | B2 |
7331957 | Woloszko et al. | Feb 2008 | B2 |
RE40156 | Sharps et al. | Mar 2008 | E |
7346391 | Osorio et al. | Mar 2008 | B1 |
7386350 | Vilims | Jun 2008 | B2 |
7387625 | Hovda et al. | Jun 2008 | B2 |
7393351 | Woloszko et al. | Jul 2008 | B2 |
7422585 | Eggers et al. | Sep 2008 | B1 |
7429262 | Woloszko et al. | Sep 2008 | B2 |
7435247 | Woloszko et al. | Oct 2008 | B2 |
7442191 | Hovda et al. | Oct 2008 | B2 |
7468059 | Eggers et al. | Dec 2008 | B2 |
7480533 | Cosman et al. | Jan 2009 | B2 |
7502652 | Gaunt et al. | Mar 2009 | B2 |
7507236 | Eggers et al. | Mar 2009 | B2 |
7553307 | Bleich et al. | Jun 2009 | B2 |
7555343 | Bleich | Jun 2009 | B2 |
7645277 | McClurken et al. | Jan 2010 | B2 |
7738968 | Bleich | Jun 2010 | B2 |
7740631 | Bleich et al. | Jun 2010 | B2 |
7749218 | Pellegrino et al. | Jul 2010 | B2 |
7819826 | Diederich et al. | Oct 2010 | B2 |
7819869 | Godara et al. | Oct 2010 | B2 |
7824398 | Woloszko et al. | Nov 2010 | B2 |
7824404 | Godara et al. | Nov 2010 | B2 |
7857813 | Schmitz et al. | Dec 2010 | B2 |
7901403 | Woloszko et al. | Mar 2011 | B2 |
7909827 | Reiley et al. | Mar 2011 | B2 |
7917222 | Osorio et al. | Mar 2011 | B1 |
7918849 | Bleich et al. | Apr 2011 | B2 |
7945331 | Vilims | May 2011 | B2 |
7963915 | Bleich | Jun 2011 | B2 |
8066702 | Rittman, III et al. | Nov 2011 | B2 |
8083736 | McClurken et al. | Dec 2011 | B2 |
8100896 | Podhajsky | Jan 2012 | B2 |
8192424 | Woloszko et al. | Jun 2012 | B2 |
8192435 | Bleich et al. | Jun 2012 | B2 |
8265747 | Rittman, III et al. | Sep 2012 | B2 |
8282628 | Paul et al. | Oct 2012 | B2 |
8292887 | Woloszko et al. | Oct 2012 | B2 |
8323279 | Dahla et al. | Dec 2012 | B2 |
8355791 | Moffitt | Jan 2013 | B2 |
8361067 | Pellegrino et al. | Jan 2013 | B2 |
8414509 | Diederich et al. | Apr 2013 | B2 |
8414571 | Pellegrino et al. | Apr 2013 | B2 |
8419730 | Pellegrino et al. | Apr 2013 | B2 |
8419731 | Pellegrino et al. | Apr 2013 | B2 |
8425507 | Pellegrino et al. | Apr 2013 | B2 |
8535309 | Pellegrino et al. | Sep 2013 | B2 |
8613744 | Pellegrino et al. | Dec 2013 | B2 |
8623014 | Pellegrino et al. | Jan 2014 | B2 |
8628528 | Pellegrino et al. | Jan 2014 | B2 |
20010001314 | Davison et al. | May 2001 | A1 |
20010001811 | Burney et al. | May 2001 | A1 |
20010020167 | Woloszko et al. | Sep 2001 | A1 |
20010023348 | Ashley et al. | Sep 2001 | A1 |
20010025176 | Ellsberry et al. | Sep 2001 | A1 |
20010025177 | Woloszko et al. | Sep 2001 | A1 |
20010029370 | Hodva et al. | Oct 2001 | A1 |
20010029373 | Baker et al. | Oct 2001 | A1 |
20010032001 | Ricart et al. | Oct 2001 | A1 |
20010047167 | Heggeness | Nov 2001 | A1 |
20010049522 | Eggers et al. | Dec 2001 | A1 |
20010051802 | Woloszko et al. | Dec 2001 | A1 |
20010056280 | Underwood et al. | Dec 2001 | A1 |
20020016600 | Cosman | Feb 2002 | A1 |
20020019626 | Sharkey et al. | Feb 2002 | A1 |
20020026186 | Woloszko et al. | Feb 2002 | A1 |
20020052600 | Davison et al. | May 2002 | A1 |
20020068930 | Tasto et al. | Jun 2002 | A1 |
20020095151 | Dahla et al. | Jul 2002 | A1 |
20020095152 | Ciarrocca et al. | Jul 2002 | A1 |
20020099366 | Dahla et al. | Jul 2002 | A1 |
20020120259 | Lettice et al. | Aug 2002 | A1 |
20020147444 | Shah et al. | Oct 2002 | A1 |
20020151885 | Underwood et al. | Oct 2002 | A1 |
20020188284 | To et al. | Dec 2002 | A1 |
20020193789 | Underwood et al. | Dec 2002 | A1 |
20030009164 | Woloszko et al. | Jan 2003 | A1 |
20030014047 | Woloszko et al. | Jan 2003 | A1 |
20030028189 | Woloszko et al. | Feb 2003 | A1 |
20030040742 | Underwood et al. | Feb 2003 | A1 |
20030055418 | Tasto et al. | Mar 2003 | A1 |
20030084907 | Pacek et al. | May 2003 | A1 |
20030097126 | Woloszko et al. | May 2003 | A1 |
20030097129 | Davison et al. | May 2003 | A1 |
20030130655 | Woloszko et al. | Jul 2003 | A1 |
20030158545 | Hovda et al. | Aug 2003 | A1 |
20030181963 | Pellegrino et al. | Sep 2003 | A1 |
20030208194 | Hovda et al. | Nov 2003 | A1 |
20030216725 | Woloszko et al. | Nov 2003 | A1 |
20030216726 | Eggers et al. | Nov 2003 | A1 |
20040006339 | Underwood et al. | Jan 2004 | A1 |
20040024399 | Sharps et al. | Feb 2004 | A1 |
20040054366 | Davison et al. | Mar 2004 | A1 |
20040087937 | Eggers et al. | May 2004 | A1 |
20040133124 | Bates et al. | Jul 2004 | A1 |
20040162559 | Arramon | Aug 2004 | A1 |
20040193151 | To et al. | Sep 2004 | A1 |
20040220577 | Cragg et al. | Nov 2004 | A1 |
20040230190 | Dahla et al. | Nov 2004 | A1 |
20050004634 | Ricart et al. | Jan 2005 | A1 |
20050010203 | Edwards et al. | Jan 2005 | A1 |
20050010205 | Hovda et al. | Jan 2005 | A1 |
20050182417 | Pagano | Aug 2005 | A1 |
20050192564 | Cosman et al. | Sep 2005 | A1 |
20050209659 | Pellegrino et al. | Sep 2005 | A1 |
20050283148 | Janssen et al. | Dec 2005 | A1 |
20060004369 | Patel et al. | Jan 2006 | A1 |
20060064101 | Arramon | Mar 2006 | A1 |
20060095026 | Ricart et al. | May 2006 | A1 |
20060095028 | Bleich | May 2006 | A1 |
20060122458 | Bleich | Jun 2006 | A1 |
20060129101 | McGuckin | Jun 2006 | A1 |
20060178670 | Woloszko et al. | Aug 2006 | A1 |
20060229625 | Truckai et al. | Oct 2006 | A1 |
20060253117 | Hovda et al. | Nov 2006 | A1 |
20060264957 | Cragg et al. | Nov 2006 | A1 |
20060276749 | Selmon et al. | Dec 2006 | A1 |
20070118142 | Krueger et al. | May 2007 | A1 |
20070129715 | Eggers et al. | Jun 2007 | A1 |
20070149966 | Dahla et al. | Jun 2007 | A1 |
20070179497 | Eggers et al. | Aug 2007 | A1 |
20070260237 | Sutton et al. | Nov 2007 | A1 |
20080004621 | Dahla et al. | Jan 2008 | A1 |
20080004675 | King et al. | Jan 2008 | A1 |
20080009847 | Ricart et al. | Jan 2008 | A1 |
20080021447 | Davison et al. | Jan 2008 | A1 |
20080021463 | Georgy | Jan 2008 | A1 |
20080058707 | Ashley et al. | Mar 2008 | A1 |
20080114364 | Goldin et al. | May 2008 | A1 |
20080119844 | Woloszko et al. | May 2008 | A1 |
20080119846 | Rioux | May 2008 | A1 |
20080132890 | Woloszko et al. | Jun 2008 | A1 |
20080161804 | Rioux et al. | Jul 2008 | A1 |
20080275458 | Bleich et al. | Nov 2008 | A1 |
20090030308 | Bradford et al. | Jan 2009 | A1 |
20090069807 | Eggers et al. | Mar 2009 | A1 |
20090105775 | Mitchell et al. | Apr 2009 | A1 |
20090118731 | Young et al. | May 2009 | A1 |
20090131867 | Liu et al. | May 2009 | A1 |
20090131886 | Liu et al. | May 2009 | A1 |
20090222053 | Gaunt et al. | Sep 2009 | A1 |
20090312764 | Marino | Dec 2009 | A1 |
20100016929 | Prochazka | Jan 2010 | A1 |
20100023006 | Ellman | Jan 2010 | A1 |
20100082033 | Germain | Apr 2010 | A1 |
20100094269 | Pellegrino et al. | Apr 2010 | A1 |
20100114098 | Carl | May 2010 | A1 |
20100145424 | Podhajsky et al. | Jun 2010 | A1 |
20100185161 | Pellegrino et al. | Jul 2010 | A1 |
20100211076 | Germain et al. | Aug 2010 | A1 |
20100222777 | Sutton et al. | Sep 2010 | A1 |
20100298832 | Lau et al. | Nov 2010 | A1 |
20100324506 | Pellegrino et al. | Dec 2010 | A1 |
20110022133 | Diederich et al. | Jan 2011 | A1 |
20110034884 | Pellegrino et al. | Feb 2011 | A9 |
20110040362 | Godara et al. | Feb 2011 | A1 |
20110077628 | Hoey et al. | Mar 2011 | A1 |
20110087314 | Diederich et al. | Apr 2011 | A1 |
20110196361 | Vilims | Aug 2011 | A1 |
20110264098 | Cobbs | Oct 2011 | A1 |
20110276001 | Schultz et al. | Nov 2011 | A1 |
20110319765 | Gertner et al. | Dec 2011 | A1 |
20120029420 | Rittman, III et al. | Feb 2012 | A1 |
20120196251 | Taft et al. | Aug 2012 | A1 |
20120197344 | Taft et al. | Aug 2012 | A1 |
20120203219 | Evans et al. | Aug 2012 | A1 |
20120226273 | Nguyen et al. | Sep 2012 | A1 |
20120239050 | Linderman | Sep 2012 | A1 |
20120330180 | Pellegrino et al. | Dec 2012 | A1 |
20120330300 | Pellegrino et al. | Dec 2012 | A1 |
20120330301 | Pellegrino et al. | Dec 2012 | A1 |
20130006232 | Pellegrino et al. | Jan 2013 | A1 |
20130006233 | Pellegrino et al. | Jan 2013 | A1 |
20130012933 | Pellegrino et al. | Jan 2013 | A1 |
20130012935 | Pellegrino et al. | Jan 2013 | A1 |
20130012936 | Pellegrino et al. | Jan 2013 | A1 |
20130103022 | Pellegrino et al. | Apr 2013 | A1 |
20130261507 | Diederich et al. | Oct 2013 | A1 |
20130324994 | Pellegrino et al. | Dec 2013 | A1 |
20130324996 | Pellegrino et al. | Dec 2013 | A1 |
20130324997 | Pellegrino et al. | Dec 2013 | A1 |
20140039500 | Pellegrino et al. | Feb 2014 | A1 |
Number | Date | Country |
---|---|---|
0040658 | Dec 1981 | EP |
0584959 | Mar 1994 | EP |
0597463 | May 1994 | EP |
1013228 | Jun 2000 | EP |
1059067 | Dec 2000 | EP |
1059087 | Dec 2000 | EP |
6-47058 | Feb 1994 | JP |
2001-037760 | Feb 2001 | JP |
2002-531229 | Sep 2002 | JP |
WO 9636289 | Nov 1996 | WO |
WO 9827876 | Jul 1998 | WO |
WO 9834550 | Aug 1998 | WO |
WO 9919025 | Apr 1999 | WO |
WO 9944519 | Sep 1999 | WO |
WO 9948621 | Sep 1999 | WO |
WO 0021448 | Apr 2000 | WO |
WO 0033909 | Jun 2000 | WO |
WO 0049978 | Aug 2000 | WO |
WO 0056237 | Sep 2000 | WO |
WO 0067648 | Nov 2000 | WO |
WO 0067656 | Nov 2000 | WO |
WO 0101877 | Jan 2001 | WO |
WO 0126570 | Apr 2001 | WO |
WO 0145579 | Jun 2001 | WO |
WO 0157655 | Aug 2001 | WO |
WO 0205699 | Jan 2002 | WO |
WO 0228302 | Apr 2002 | WO |
WO 02054941 | Jul 2002 | WO |
WO 02067797 | Sep 2002 | WO |
WO 02096304 | Dec 2002 | WO |
WO2007031264 | Mar 2007 | WO |
WO 2008008522 | Jan 2008 | WO |
WO 2008121259 | Oct 2008 | WO |
Entry |
---|
The AVAmax System—Cardinal Health Special Procedures, Lit. No. 25P0459-01—www.cardinal.com (2007). |
Mary S. Sherman; The Nerves of Bone, The Journal of Bone and Joint Surgery, Apr. 1963, pp. 522-528, vol. 45-A, No. 3. |
Michael H. Heggeness, et al., The Trabecular Anatomy of Thoracolumbar Vertebrae: Implications for Burst Fractures, Journal of Anatomy, 1997, pp. 309-312, vol. 191, Great Britain. |
J.B. Martin, et al., Vertebroplasty: Clinical Experience and Follow-up Results, Bone, Aug. 1999, pp. 11S-15S, vol. 25, No. 2, Supplement. |
H. Deramond, et al., Temperature Elevation Caused by Bone Cement Polymerization During Vertebroplasty, Bone, Aug. 1999, pp. 17S-21S, vol. 25, No. 2, Supplement. |
D.E. Dupuy et al. Radiofrequency ablation of spinal tumors: Temperature distribution in the spinal canal AJR, vol. 175, pp. 1263-1266, Nov. 2000. |
C.L. Tillotson et al. Controlled thermal injury of bone: Report of a percutaneous technique using radiofrequency electrode and generator. Investigative Radiology, Nov. 1989, pp. 888-892. |
Cosman, E.R. et al. Theoretical Aspects of Radiofrequency Lesions in the Dorsal Root Entry Zone. Neurosurgery, vol. 1, No. 6, 1984, pp. 945-950. |
S.N. Goldberg et al. Tissue ablation with radiofrequency: Effect of probe size, gauge, duration, and temperature on lesion volume, Acad. Radiol., vol. 2, pp. 399-404 (1995). |
D.I. Rosenthal. Seminars in Musculoskeletal Radiology, vol. 1, No. 2, pp. 265-272 (1997). |
L. Solbiati et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Interventional Radiology, vol. 205, No. 2, pp. 367-373 (1997). |
Massad, Malek M.D. et al.; Endoscopic Thoracic Sympathectomy: Evaluation of Pulsatile Laser, Non-Pulsatile Laser, and Radiofrequency-Generated Thermocoagulation; Lasers in Surgery and Medicine; 1991; pp. 18-25. |
Kleinstueck, Frank S. et al.; Acute Biomechanical and Histological Effects of Intradiscal Electrothermal Therapy on Human Lumbar Discs; SPINE vol. 26, No. 20, pp. 2198-2207; 2001, Lippincott Williams & Wilkins, Inc. |
Heggeness, Michael H. et al. Discography Causes End Plate Deflection; SPINE vol. 18, No. 8, pp. 1050-1053, 1993, J.B. Lippincott Company. |
Letcher, Frank S. et al.; The Effect of Radiofrequency Current and Heat on Peripheral Nerve Action Potential in the Cat; U.S. Naval Hospital, Philadelphia, PA (1968). |
Houpt, Jonathan C. et al.; Experimental Study of Temperature Distributions and Thermal Transport During Radiofrequency Current Therapy of the Intervertebral Disc; SPINE vol. 21, No. 15, pp. 1808-1813, 1996, Lippincott-Raven Publishers. |
Lundskog, Jan; Heat and Bone Tissue-/an experimental investigation of the thermal properties of bone tissue and threshold levels for thermal injury; Scandinavian Journal of Plastic and Reconstructive Surgery Supplemental 9, From the Laboratory of Experimental Biology, Department of anatomy, University of Gothenburg, Gothenburg, Sweden, Goteborg (1972). |
Antonacci, M. Darryl et al.; Innervation of the Human Vertebral Body: A Histologic Study; Journal of Spinal Disorder, vol. 11, No. 6, pp. 526-531, 1998 Lippincott Williams & Wilkins, Philadelphia. |
Arnoldi, Carl C.; Intraosseous Hypertension—A Possible Cause of Low Back Pain?; Clinical Orthopedics and Related Research, No. 115, Mar.-Apr. 1976. |
Esses, Stephen I. et al.; Intraosseous Vertebral Body Pressures; SPINE vol. 17 No. 6 Supplement (1992). |
Troussier, B. et al.; Percutaneous Intradiscal Radio-Frequency Thermocoagulation A Cadaveric Study; SPINE vol. 20, No. 15, pp. 1713-1718, 1995, Lippincott-Raven Publishers. |
Choy, Daniel SS.J. et al.; Percutaneous Laser Disc Decompression, A New Therapeutic Modality; SPINE vol. 17, No. 8 (1992). |
Shealy, C. Norman; Percutaneous radiofrequency denervation of spinal facets: Treatment for chronic back pain and sciatica; Journal of Neurosurgery/vol. 43/Oct. 1975. |
Depuy, Damian E.; Radiofrequency Ablation: An Outpatient Percutaneous Treatment; Medicine and Health/Rhode Island vol. 82, No. 6, Jun. 1999. |
Rashbaum, Ralph F.; Radiofrequency Facet Denervation A Treatment alternative in Refractory Low Back Pain with or without Leg Pain; Orthopedic Clinics of North America—vol. 14, No. 3, Jul. 1983. |
Lehmann, Justus F. et al.; Selective Heating Effects of Ultrasound in Human Beings; Archives of Physical Medicine & Rehabilitation Jun. 1966. |
Hanai, Kenji et al.; Simultaneous Measurement of Intraosseous and Cerebrospinal Fluid Pressures in the Lumbar Region; SPINE vol. 10, No. 1 (1985). |
Bogduk, Nikolai, et al.; Technical Limitations to the efficacy of Radiofrequency Neurotomy for Spinal Pain; Neurosurgery vol. 20, No. 4 (1987). |
Mehta, Mark et al.; The treatment of chronic back pain; Anaesthesia, 1979, vol. 34, pp. 768-775. |
Deardorff, Dana L. et al.; Ultrasound applicators with internal cooling for interstitial thermal therapy; SPIE vol. 3594 (1999). |
Diederich, Chris J. et al.; Ultrasound Catheters for Circumferential Cardiac Ablation; SPIE vol. 3594 (1999). |
Diederich C J, et al. “IDTT Therapy in Cadaveric Lumbar Spine: Temperature and thermal dose distributions, Thermal Treatment of Tissue: Energy Delivery and Assessment,” Thomas P. Ryan, Editor, Proceedings of SPIE vol. 4247:104-108 (2001). |
Nau, William H., Ultrasound interstitial thermal therapy (USITT) in the prostate; SPIE vol. 3594 (1999). |
The AVAmax System—Cardinal Health Special Procedures, Lit. No. 25P0459-01—www.cardinal.com (allegedly dated 2007). |
Kopecky, Kenyon K. et al. “Side-Exiting Coaxial Needle for Aspiration Biopsy”—AJR—1996; 167, pp. 661-662. |
A Novel Approach for Treating Chronic Lower Back Pain, Abstract for Presentation at North American Spine Society 26th Annual Meeting in Chicago, IL on Nov. 4, 2011. |
Stanton, Terry, “Can Nerve Ablation Reduce Chronic Back Pain?” AAOS Now Jan. 2012. |
Ryan et al., “Three-Dimensional Finite Element Simulations of Vertebral Body Thermal Treatment,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 137-155. |
Bergeron et al., “Fluoroscopic-guided radiofrequency ablation of the basivertebral nerve: application and analysis with multiple imaging modalities in an ovine model,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 156-167. |
Hoopes et al., “Radiofrequency Ablation of The Basivertebral Nerve as a Potential Treatment of Back Pain: Pathologic Assessment in an Ovine Model,” Thermal Treatment of Tissue: Energy Delivery and Assessment III, edited by Thomas P. Ryan, Proceedings of SPIE, vol. 5698 (SPIE, Bellingham, WA, 2005) pp. 168-180. |
FDA Response to 510(k) Submission by Relievant Medsystems, Inc. submitted on Sep. 27, 2007 (date stamped on Oct. 5, 2007) and associated documents. |
Number | Date | Country | |
---|---|---|---|
20130103022 A1 | Apr 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12643997 | Dec 2009 | US |
Child | 13655683 | US | |
Parent | 11745446 | May 2007 | US |
Child | 12643997 | US | |
Parent | 10401854 | Mar 2003 | US |
Child | 11745446 | US |